YMAB logo

Y-mAbs Therapeutics (YMAB) Non Current Assets

Annual Non Current Assets

$21.39 M
+$4.64 M+27.67%

December 31, 2024


Summary


Performance

YMAB Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherYMABbalance sheetmetrics:

Quarterly Non Current Assets

$21.39 M
-$465.00 K-2.13%

December 31, 2024


Summary


Performance

YMAB Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherYMABbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

YMAB Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.7%0.0%
3 y3 years+103.3%+94.3%
5 y5 years+385.0%+94.3%

YMAB Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+103.3%-2.1%+103.3%
5 y5-yearat high+385.0%-2.1%+433.7%
alltimeall timeat high-100.0%-2.1%+6012.9%

Y-mAbs Therapeutics Non Current Assets History

DateAnnualQuarterly
Dec 2024
$98.51 M(-11.3%)
$21.39 M(-2.1%)
Sep 2024
-
$21.86 M(+26.6%)
Jun 2024
-
$17.27 M(+14.8%)
Mar 2024
-
$15.05 M(-10.2%)
Dec 2023
$111.11 M(-14.8%)
$16.76 M(+19.5%)
Sep 2023
-
$14.02 M(-15.6%)
Jun 2023
-
$16.61 M(+23.6%)
Mar 2023
-
$13.44 M(+22.1%)
Dec 2022
$130.45 M(-35.5%)
$11.01 M(+3.2%)
Sep 2022
-
$10.67 M(-5.2%)
Jun 2022
-
$11.26 M(-15.4%)
Mar 2022
-
$13.31 M(+26.5%)
Dec 2021
$202.26 M
$10.52 M(+11.9%)
Sep 2021
-
$9.40 M(-7.0%)
DateAnnualQuarterly
Jun 2021
-
$10.11 M(-7.3%)
Mar 2021
-
$10.91 M(+12.6%)
Dec 2020
$122.36 M(-42.3%)
$9.68 M(-3.0%)
Sep 2020
-
$9.99 M(+149.1%)
Jun 2020
-
$4.01 M(-5.4%)
Mar 2020
-
$4.24 M(-3.9%)
Dec 2019
$211.96 M(+39.9%)
$4.41 M(+7.8%)
Sep 2019
-
$4.09 M(+43.6%)
Jun 2019
-
$2.85 M(-3.8%)
Mar 2019
-
$2.96 M(+655.9%)
Dec 2018
$151.53 M(+65.9%)
$392.00 K(+12.0%)
Sep 2018
-
$350.00 K(-77.7%)
Jun 2018
-
$1.57 M(+103.2%)
Dec 2017
$91.36 M(+429.3%)
$772.00 K
Dec 2016
$17.26 M
-

FAQ

  • What is Y-mAbs Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Y-mAbs Therapeutics?
  • What is Y-mAbs Therapeutics annual non current assets year-on-year change?
  • What is Y-mAbs Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Y-mAbs Therapeutics?
  • What is Y-mAbs Therapeutics quarterly non current assets year-on-year change?

What is Y-mAbs Therapeutics annual long term assets?

The current annual non current assets of YMAB is $21.39 M

What is the all time high annual non current assets for Y-mAbs Therapeutics?

Y-mAbs Therapeutics all-time high annual long term assets is $21.39 M

What is Y-mAbs Therapeutics annual non current assets year-on-year change?

Over the past year, YMAB annual long term assets has changed by +$4.64 M (+27.67%)

What is Y-mAbs Therapeutics quarterly long term assets?

The current quarterly non current assets of YMAB is $21.39 M

What is the all time high quarterly non current assets for Y-mAbs Therapeutics?

Y-mAbs Therapeutics all-time high quarterly long term assets is $21.86 M

What is Y-mAbs Therapeutics quarterly non current assets year-on-year change?

Over the past year, YMAB quarterly long term assets has changed by $0.00 (0.00%)